Previous 10 | Next 10 |
2023-12-13 15:50:11 ET Summary Medifast partners with LifeMD to offer virtual weight management program with access to GLP-1 drugs. Medifast invests $20 million in LifeMD, with $10 million represented by common stock purchase. Survey shows over 40% of people with BMI greater t...
2023-12-13 13:37:28 ET More on AmWell, Teladoc, etc. Teladoc: High Stock Compensation Is An Issue Teladoc: No Floor Yet Teladoc's Valuation Proposition: 7x EBITDA In 2024, Not So Bad Global telemedicine market to hit $450B in 2032: report American Wel...
2023-12-13 07:10:47 ET More on LifeMD, Medifast LifeMD: My Tech Pick For 2024 And Its 12% Yielding Preferreds Medifast: Good On Paper, But A Slowdown In Sales Is Very Worrisome LifeMD Is The Stock To Play The Mega GLP-1 Drug Trend For further details see: ...
Collaboration will integrate LifeMD’s telehealth platform and GLP-1 offering for medically qualified patients with OPTA VIA Coach-guided, healthy lifestyle solution Medifast has invested $20 million, including a $10 million payment in support of the collaboration ...
NEW YORK, Dec. 07, 2023 (GLOBE NEWSWIRE) -- LifeMD, Inc. ™ (Nasdaq: LFMD), a leading provider of virtual primary care, today announced its participation in the RWJBarnabas Health Telehealth Symposium on Thursday, December 14 from 10:00 a.m. – 1:00 p.m. EST. The Symposium, wh...
2023-12-01 17:29:51 ET Gainers: Terns Pharmaceuticals ( TERN ) +10% . Alkermes ( ALKS ) +9% . Forrester Research ( FORR ) +7% . Amkor Technology ( AMKR ) +5% . LifeMD ( LFMD ) +4% . Losers: James River Group Holding...
2023-11-26 19:39:06 ET Summary LifeMD is recording strong growth figures on the back of WorkSimpli, its SaaS offering. The company currently sports an 87.62% gross profit margin and generated positive operating cash flow for its most recent quarter. Gross profit margins will s...
2023-11-12 07:00:00 ET Summary LifeMD's weight management program has attracted over 16K subscribers in two quarters, producing $24M in annual recurring revenue run rate already, and this is only the beginning. Goldman Sachs argues that GLP-1 drugs are going to 16-fold by 2030 and...
NEW YORK, Nov. 10, 2023 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced that management will be participating in two upcoming investor conferences and a panel discussion. Cantor Fitzgerald GLP-1 Panel: Payor vs....
2023-11-09 06:05:54 ET Summary LifeMD is experiencing strong subscriber retention rates and expects significant growth in the weight management drug segment. The company's telehealth operations and subsidiary, WorkSimpli, are also contributing to its success and expected to delive...
News, Short Squeeze, Breakout and More Instantly...
NEW YORK, June 25, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD) today announced the launch of private health insurance acceptance for its virtual primary care services, including weight management for medically qualified patients. Initially available in select states, the company plan...
NEW YORK, June 10, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, announces that management will be participating in the Truist Securities Healthcare Disruptors & Digital Health Summit taking place June 25-26, 2024 at the Lot...